Novo Nordisk A/S (CPH:NOVO.B)
442.95
-3.35 (-0.75%)
May 23, 2025, 4:59 PM CET
Novo Nordisk Employees
As of December 31, 2024, Novo Nordisk had 77,349 total employees, including 76,302 full-time and 1,047 part-time employees. The number of employees increased by 13,030 or 20.26% compared to the previous year.
Employees
77,349
Change (1Y)
13,030
Growth (1Y)
20.26%
Revenue / Employee
3.92M DKK
Profits / Employee
1.35M DKK
Market Cap
1,966.28B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 77,349 | 13,030 | 20.26% |
Dec 31, 2023 | 64,319 | 9,134 | 16.55% |
Dec 31, 2022 | 55,185 | 6,707 | 13.84% |
Dec 31, 2021 | 48,478 | 3,155 | 6.96% |
Dec 31, 2020 | 45,323 | 2,065 | 4.77% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Coloplast | 16,639 |
Genmab | 2,682 |
Demant | 22,639 |
ALK-Abelló | 2,753 |
H. Lundbeck | 5,707 |
Zealand Pharma | 335 |
Ambu A/S | 5,196 |
GN Store Nord | 7,347 |
Novo Nordisk News
- 3 hours ago - Mizuho's Jared Holz talks what is next for Novo Nordisk - CNBC
- 9 hours ago - Novo Nordisk's High Risk/Reward Proposition: 129% Rally Or 65% Drop? - Benzinga
- 9 hours ago - Novo Nordisk's High Risk/Reward Proposition: 129% Rally Or 65% Drop? - Benzinga
- 1 day ago - Novo Nordisk promotes Wegovy for new customers as compounding ban takes effect - Seeking Alpha
- 1 day ago - Novo Nordisk offers Wegovy for $199 for first month to new cash-paying customers - Reuters
- 1 day ago - New Novo Nordisk initiatives support patient access to authentic, FDA-approved Wegovy® as federal ban on mass compounding of "semaglutide" takes effect - PRNewsWire
- 1 day ago - Focus: Novo Nordisk's former chief makes comeback to steer choice of new CEO - Reuters
- 1 day ago - Pressure is mounting on Lund at BP and Novo Nordisk - Financial Times